Forecus

ForeCus is a South Korean biotechnology company dedicated to the discovery and development of novel therapeutics for neurodegenerative and metabolic diseases. The company utilizes a proprietary artificial intelligence (AI) platform to streamline the drug discovery process, focusing on identifying high-affinity small molecules for complex targets. Its primary research programs are centered on Alzheimer's disease and Parkinson's disease, aiming to provide disease-modifying treatments where current options are limited. By integrating computational modeling with experimental validation, ForeCus seeks to accelerate the timeline from initial target identification to clinical entry.